Nautilus Biotechnology, Inc.

NasdaqGS:NAUT Stock Report

Market Cap: US$216.0m

Nautilus Biotechnology Management

Management criteria checks 2/4

Nautilus Biotechnology's CEO is Sujal Patel, appointed in Jun 2021, has a tenure of 3.58 years. directly owns 13.67% of the company’s shares, worth $29.51M. The average tenure of the management team and the board of directors is 3.6 years and 3.6 years respectively.

Key information

Sujal Patel

Chief executive officer

US$1.9m

Total compensation

CEO salary percentagen/a
CEO tenure3.6yrs
CEO ownership13.7%
Management average tenure3.6yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

We're Not Very Worried About Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate

Jul 27
We're Not Very Worried About Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate

We Think Nautilus Biotechnology (NASDAQ:NAUT) Can Afford To Drive Business Growth

Feb 16
We Think Nautilus Biotechnology (NASDAQ:NAUT) Can Afford To Drive Business Growth

Companies Like Nautilus Biotechnology (NASDAQ:NAUT) Are In A Position To Invest In Growth

Oct 22
Companies Like Nautilus Biotechnology (NASDAQ:NAUT) Are In A Position To Invest In Growth

We're Not Very Worried About Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate

May 25
We're Not Very Worried About Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate

We Think Nautilus Biotechnology (NASDAQ:NAUT) Can Afford To Drive Business Growth

Feb 17
We Think Nautilus Biotechnology (NASDAQ:NAUT) Can Afford To Drive Business Growth

Nautilus Biotechnology Q2 2022 Earnings Preview

Aug 01

The Take On Nautilus Biotechnology

Jan 17

Nautilus Biotechnology: Recent Selloff Provides A Fantastic Entry Point

Jan 07

Nautilus Biotechnology: Tapping The Potential Of The Human Proteome

Aug 30

CEO Compensation Analysis

How has Sujal Patel's remuneration changed compared to Nautilus Biotechnology's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$70m

Jun 30 2024n/an/a

-US$70m

Mar 31 2024n/an/a

-US$67m

Dec 31 2023US$2mn/a

-US$64m

Sep 30 2023n/an/a

-US$60m

Jun 30 2023n/an/a

-US$58m

Mar 31 2023n/an/a

-US$57m

Dec 31 2022US$2mUS$500k

-US$58m

Sep 30 2022n/an/a

-US$61m

Jun 30 2022n/an/a

-US$62m

Mar 31 2022n/an/a

-US$58m

Dec 31 2021US$7mUS$437k

-US$50m

Sep 30 2021n/an/a

-US$39m

Jun 30 2021n/an/a

-US$28m

Mar 31 2021n/an/a

-US$21m

Dec 31 2020US$251kUS$200k

-US$16m

Compensation vs Market: Sujal's total compensation ($USD1.89M) is above average for companies of similar size in the US market ($USD1.38M).

Compensation vs Earnings: Sujal's compensation has increased whilst the company is unprofitable.

CEO

Sujal Patel (49 yo)

3.6yrs

Tenure

US$1,892,862

Compensation

Mr. Sujal M. Patel serves as the Sage at Defy Partners since joining the firm in April 2019. He is Co-Founder of Nautilus Biotechnology, Inc. and has been its Chief Executive Officer, President, Secretary...

Leadership Team

NamePositionTenureCompensationOwnership
Sujal Patel
Co-Founder3.6yrsUS$1.89m13.67%
$ 29.5m
Parag Mallick
Co-Founder3.6yrsUS$1.02m16.47%
$ 35.6m
Anna Mowry
CFO & Treasurer3.6yrsUS$781.52k0.048%
$ 104.1k
Matthew Murphy
General Counsel3.6yrsUS$2.87mno data
Chris Blessington
Vice President of Corporate Marketing & Communications4yrsno datano data
Kentaro Suzuki
Chief Marketing Officerless than a yearno datano data
Gwen Weld
Chief People Officer2.8yrsUS$1.87m0.024%
$ 51.6k
Nick Nelson
Chief Business Officer & Senior VP of Business Development3.6yrsno datano data
Subra Sankar
Senior Vice President of Product Development3.6yrsUS$2.91mno data

3.6yrs

Average Tenure

49yo

Average Age

Experienced Management: NAUT's management team is considered experienced (3.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sujal Patel
Co-Founder3.6yrsUS$1.89m13.67%
$ 29.5m
Parag Mallick
Co-Founder3.6yrsUS$1.02m16.47%
$ 35.6m
Farzad Nazem
Independent Director3.6yrsUS$189.98k1.5%
$ 3.2m
Matthew McIlwain
Independent Director3.6yrsUS$202.98k0.37%
$ 789.6k
Ruedi Aebersold
Member of Scientific Advisory Boardno datano datano data
Leland Hartwell
Member of Scientific Advisory Boardno datano datano data
Vijay Pande
Independent Director3.6yrsUS$187.98k0%
$ 0
Matthew Posard
Independent Chairman of the Board3.6yrsUS$246.98k0.12%
$ 258.0k
Melissa Epperly
Independent Director3.6yrsUS$202.98k0%
$ 0
Michael Altman
Independent Director3.6yrsUS$189.98k0.13%
$ 285.3k
Emma Lundberg
Member of Scientific Advisory Board3.6yrsno datano data
Joshua LaBaer
Member of Scientific Advisory Boardno datano datano data

3.6yrs

Average Tenure

51yo

Average Age

Experienced Board: NAUT's board of directors are considered experienced (3.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 14:22
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nautilus Biotechnology, Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew SykesGoldman Sachs
Subhalaxmi NambiGuggenheim Securities, LLC
Brandon CouillardJefferies LLC